Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sociedad de Lucha Contra el Cáncer (SOLCA) is the preeminent oncology healthcare network in Ecuador, functioning as a private non-profit organization focused on the prevention, diagnosis, and treatment of cancer. Founded in 1951, the organization operates a comprehensive network of specialized hospitals and institutes across major Ecuadorian cities, including Guayaquil, Quito, and Cuenca. SOLCA provides high-complexity medical services such as advanced radiotherapy, chemotherapy, and hematopoietic stem cell transplantation. Beyond clinical services, the institution is a leader in oncological research and maintains the National Tumor Registry, which is essential for cancer epidemiology in South America. It plays a vital role in the Ecuadorian health system by providing specialized care to both public and private sector patients through a unique funding model supported by national legislation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sociedad de Lucha Contra el Cáncer.